MedPath

SKIN TO SKIN CONTACT BETWEEN MOTHER AND BABY TO REDUCE THE TREATMENT DURATION FOR JAUNDICE

Not Applicable
Conditions
Health Condition 1: P599- Neonatal jaundice, unspecified
Registration Number
CTRI/2023/04/051798
Lead Sponsor
Dr Srinivas Murki
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Babies requiring phototherapy

Mother available

Gestation more than or equal to 34 weeks

Exclusion Criteria

Evidence of hemolysis

TSB in the exchange zone

TSB > 18 mg/dl

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Rate of fall in serum bilirubinTimepoint: Till discharge
Secondary Outcome Measures
NameTimeMethod
1. Rate of successful breastfeeding defined as breastfeeding more than or equal to 75% of feeds at the time of discharge <br/ ><br>2. Weight trends during therapy <br/ ><br>3. Duration of hospital stay <br/ ><br>4. Duration of phototherapy <br/ ><br>5. Requirement of exchange transfusion / Hypothermia / hyperthermia during skin to skin contact <br/ ><br>6. Incidence of rebound jaundice. <br/ ><br>Timepoint: Till discharge
© Copyright 2025. All Rights Reserved by MedPath